Related Experiment Video
Updated: May 30, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients
Masaki Honda1, Hidekazu Yamamoto, Shintaro Hayashida
1Department of Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan.
Insights
Pediatric liver transplant patients frequently develop thrombocytopenia. Preoperative platelet count, graft-to-recipient weight ratio, and acute rejection are key predictors of this condition post-transplant.
Area of Science:
- Pediatric Hepatology
- Transplantation Immunology
- Hematology
Background:
- Thrombocytopenia is a frequent complication following liver transplantation (LT) in pediatric patients with end-stage liver disease.
- Understanding the incidence and predictors of post-transplant thrombocytopenia (PLT) is crucial for optimizing patient outcomes.
Purpose of the Study:
- To evaluate the incidence of thrombocytopenia in pediatric patients after living donor liver transplantation (LDLT).
- To identify predictive factors associated with post-transplant thrombocytopenia (PLT <100,000/mm³).
Main Methods:
- Retrospective analysis of 76 pediatric patients (≤15 years) who underwent LDLT.
- Evaluation of platelet counts at two weeks and 12 months post-transplant.
- Univariate and multivariate analyses to determine associations with thrombocytopenia.
Main Results:
- Prevalence of thrombocytopenia was 28.9% at two weeks and 17.7% at 12 months post-LDLT.
- Early thrombocytopenia was associated with age at transplant, preoperative platelet count, graft-to-recipient weight ratio (GRWR), acute rejection, and CMV infection.
- Preoperative platelet count, GRWR, and acute rejection were significant predictors in multivariate analysis; preoperative platelet count was the sole predictor at 12 months.
Conclusions:
- Preoperative platelet count, GRWR, and acute rejection are significant factors influencing thrombocytopenia after pediatric LDLT.
- Post-operative monitoring of platelets aids in early detection of adverse events related to the liver graft.
- Successful treatment of vascular complications led to platelet count recovery.
Abstract:
Thrombocytopenia is common after LT for pediatric end-stage liver diseases. Seventy-six pediatric patients (≤15 yr old) who underwent LDLT were evaluated for the incidence and predictive factors of post-transplant thrombocytopenia (PLT <100, 000/mm(3) ). The prevalence of thrombocytopenia at two wk and at 12 months post-transplant was 22/76 (28.9%) and 11/62 (17.7%), respectively. Thrombocytopenia at two wk after LDLT was significantly associated with age at transplant, preoperative PLT, GRWR, acute rejection, and CMV infection in univariate analysis. Moreover, preoperative PLT, GRWR, and acute rejection had a strong correlation in multivariate analysis. Thrombocytopenia at 12 months after LDLT was associated only with preoperative PLT. We also demonstrated that vascular complications caused thrombocytopenia and that successful treatment recovered the PLT. These results showed that, in addition to considering the preoperative PLT, post-operative monitoring of platelets is very helpful for the early detection of adverse events related to the graft liver in pediatric liver transplant patients.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
12:27Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test